Together with our data that CerK is implicated in migration and invasion by activating PI3K and Akt signaling in metastatic cells, this warrants further investigation to better understand the pro-malignant function of CerK and to assess the therapeutic potential of CerK targeting in breast cancer. This evidence concerns the gene AKT1 and breast carcinoma.